ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Iksuda Therapeutics exercises licensing rights from University of Goettingen
October 16, 2020UK-based biotech company Iksuda Therapeutics has executed its option to secure exclusive worldwide rights to develop a new class of tumour-activated prodrug payloads from the University of Goettingen. -
LegoChem Biosciences, Iksuda collaborate to develop antibody-drug conjugates
April 22, 2020LegoChem Biosciences, based in Daejeon, South Korea, announced that it has entered a research collaboration and license agreement with Iksuda Therapeutics for the development of antibody-drug conjugates in oncology.
Pharma Sources Insight January 2025
